Science & Technology
High-Dose and Sustained Delivery of Hiv-1 Broadly Neutralizing Antibodies Via Subcutaneous Injection of Hydrogel-Based Microparticle Formations
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N93024C00047
Award Ceiling
$295K
Award Floor
$295K
Close Date
N/A
Total Funding
$295K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N93024C00047
Description
SBIR Phase Phase I award: "HIGH-DOSE AND SUSTAINED DELIVERY OF HIV-1 BROADLY NEUTRALIZING ANTIBODIES VIA SUBCUTANEOUS INJECTION OF HYDROGEL-BASED MICROPARTICLE FORMATIONS" awarded to ACOUSTICABIO, INC. in CAMBRIDGE, Massachusetts. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $295,116. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.